An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot

Inclusion Criteria: * Be co-operative, reliable and sufficiently competent to grade and record symptoms as requested * have a clinical diagnosis of uncomplicated interdigital Tinea pedis confirmed by KOH microscopy * Be either post-menopausal or surgically sterile, abstinent, or, if sexually active, be practicing an effective method of birth control before entry and throughout the study and have a negative urine pregnancy test at screening (applies to women only) * Sign an informed consent form indicating an understanding of the purpose of and procedures required for the study and willingness to participate in the study Exclusion Criteria: * Have complicated Tinea pedis defined as confluent, diffuse moccasin type tinea pedis of the entire plantar surface (undersurface of foot), onychomycosis (fungal nail infection) * other dermatomycosis (fungal skin infection) requiring active treatment * Have a previous sensitivity to imidazole antifungal agents or to any ingredient of the study medication * Have a history of disallowed therapies including oral (by mouth) antifungal treatments within the previous 6 weeks, recent use (within 2 weeks of the study start) of topical antifungal agent, immunosuppressive or radiation therapy within the previous 4 weeks, recent use (within 2 weeks prior to screening) of other oral antibiotics, systemic corticosteroids or topical corticosteroids or antibiotics applied to the feet * Be HIV-positive (testing will not be performed) * Have uncontroll…